Lemaitre Vascular Inc. (LMAT)
NASDAQ · Healthcare
Lemaitre Vascular Inc. EBITDA 2020–2025
Lemaitre Vascular Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Lemaitre Vascular Inc. ebitda for the quarter ending March 31, 2026 was 20.3 M, a 12.10% increase year-over-year.
- Lemaitre Vascular Inc. ebitda for the twelve months ending March 31, 2026 was 93.0 M.
- Lemaitre Vascular Inc. annual ebitda for 2025 was 77.7 M, a 16.39% increase from 2024.
- Lemaitre Vascular Inc. annual ebitda for 2024 was 66.8 M, a 34.92% increase from 2023.
- Lemaitre Vascular Inc. annual ebitda for 2023 was 49.5 M, a 23.59% increase from 2022.
- Lemaitre Vascular Inc. annual ebitda for 2022 was 40.0 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lemaitre Vascular Inc. EBITDA — FAQ
Lemaitre Vascular Inc. (LMAT) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LMAT's ebitda history?
The chart and table above show Lemaitre Vascular Inc.'s ebitda by year and by quarter, including the growth rate.